One possibility is that the AF phenotype observed in a model of FGFR2 loss of function leads to excess unbound ligand that can diffuse and activate signaling in regions where FGF signaling is normally low, recapitulating a gain of function via other receptors. Here, FGFR2 is linked to atrial fibrillation.